[终身抗精神病药物吗?没有. 关于逐步淘汰的问题的定性分析]
Tijdschrift voor psychiatrie
|February 24, 2026
概括
许多使用抗精神病药物的人希望因副作用或缺乏益处而停止治疗. 这项研究分析了用户的问题,以了解有关逐渐减少抗精神病药物和戒断的担忧.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 心理健康研究 心理健康研究
背景情况:
- 许多患者因副作用,功能障碍或缺乏疗效而停止服用抗精神病药物.
- 停止或减少抗精神病药物剂量的患者主导的决定是常见的.
- 了解患者的动机和担忧对于有效的治疗管理至关重要.
研究的目的:
- 识别和分析抗精神病药物使用者及其家属关于停止或逐渐减少这些药物的具体问题.
- 探索患者和患者对停止抗精神病治疗的相关观点.
主要方法:
- 对一个以心理健康为重点的公开匿名问答论坛的分析.
- 具体涉及停止或逐渐减少抗精神病药物的问题的诱导性内容分析.
- 选3000个问题,确定426个关于抗精神病药物的问题,其中194个关注戒断或逐渐减少.
主要成果:
- 主要问题是停止服用抗精神病药物的建议性.
- 关键问题包括逐渐减少的速度,最小有效剂量,支持的可用性和戒断症状的持续时间.
- 停止的动机是副作用,功能困难和缺乏感知到的益处.
- 障碍物包括支持不足和症状复发,而促进者包括社会支持和症状缓解.
结论:
- 抗精神病药物使用者及其亲属有许多关于停止服用药物的未解答问题.
- 这些问题突出了重要患者的态度,偏好和担忧,需要在临床讨论中解决.
- 解决这些知识差距可以改善关于抗精神病治疗的共同决策.
相关概念视频
Psychosis: Goals of Pharmacotherapy
639
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
639
Drug Administration and Therapy Phases: Overview
1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K
Drug Therapy
322
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
322
Pharmacodynamics in Geriatric Patients: Effects of Age
278
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
278
Preclinical Development: Overview
6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
Drug Dosing: Geriatric Patients
321
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
321


